SlideShare a Scribd company logo
By- Vijaiy. S & Shreedevi. R
RVS COLLEGE OF PHARMACY, SULUR, COIMBATORE,
TAMILNADU.
INTRODUCTION
• It is a slowly progressive degenerative disease of nervous system
associated with damage to basal ganglia followed by destruction of
substantia nigra.
• This causes decrease in dopamine level causing parkinsons diseases.
• It was discovered by English physician James Parkinson in 1817.
• It is also called as Parkinsonism/Paralysis agitans.
• It is found to be 14th major cause for death in US.
PATHOPHYSIOLOGY
SYMPTOMS
• Mild noticeable tremor in one hand.
• Bradykinesia
• Rigid muscles.
• Poverty of movements-Loss of activties
including blinking,smiling etc.
• Gait
• Emotional changes.
• Dementia.
• And due to stages
CAUSES
• Encephalitis
• Cerebral arteriosclerosis
• Drugs - Prolonged use of Antihpertensive drugs (Eg:Reserpine)
• Low levels of dopamine and norepinephrine, a substance that
regulates dopamine, have been linked with Parkinson’s.
• Research has identified groups of people who are more likely to develop
the condition. These include:
• Sex: Men are one and a half times more likely to get Parkinson’s than
women.
• Race: Whites are more likely to get Parkinson’s than African Americans
or Asians.
• Age: Parkinson’s usually appears between the ages of 50 and 60. It
only occurs before the age of 40 in 5-10 percent of cases.
• Family history: People who have close family members with
Parkinson’s disease are more likely to develop Parkinson’s disease, too.
• Toxins: Exposure to certain toxins may increase the risk of Parkinson’s
disease.
• Head injury: People who experience head injuries may be more likely
to develop Parkinson’s disease.
STAGES OF PARKINSON’S DISEASE
Stage one of Parkinson’s disease
• The symptoms of PD are mild and only seen on one
side of the body (unilateral involvement), and there is
usually minimal or no functional impairment
• Symptoms at stage one may include tremor, such as
intermittent tremor of one hand, rigidity, or one hand
or leg may feel more clumsy than another, or one side
of the face may be affected, impacting the expression.
• This stage is very difficult to diagnose and a physician
may wait to see if the symptoms get worse over time
before making a formal diagnosis
Stage two of Parkinson’s disease
• It is characterized by symptoms on both sides of the body
(bilateral involvement) or at the midline without impairment to
balance.
• Stage two may develop months or years after stage one.
Symptoms of PD in stage two may include the loss of facial
expression on both sides of the face, decreased
blinking, speech abnormalities, soft voice, monotone voice,
fading volume after starting to speak loudly, slurring speech,
stiffness or rigidity of the muscles in the trunk that may result
in neck or back pain, stooped posture, stooped posture, and
general slowness in all activities of daily living.
• Diagnosis may be easy at this stage if the patient has a
tremor.
Stage three of Parkinson’s disease
• It is considered mid-stage and is characterized by loss
of balance and slowness of movement.
• Balance is compromised by the inability to make the rapid,
automatic and involuntary adjustments necessary to
prevent falling, and falls are common at this stage.
• All other symptoms of PD are also present at this stage,
and generally diagnosis is not in doubt at stage three.
• Often a physician will diagnose impairments in reflexes at
this stage by standing behind the patient and gently pulling
the shoulders to determine if the patient has trouble
maintaining balance and falls backward (the physician of
course will not let the patient fall).
Stage four of Parkinson’s disease
• Patients with stage four PD may be able to walk and
stand unassisted, but they are noticeably
incapacitated. Many use a walker to help them.
• At this stage, the patient is unable to live an
independent life and needs assistance with some
activities of daily living. The necessity for help with
daily living defines this stage. If the patient is still able
to live alone, it is still defined as stage three.
Stage five of Parkinson’s disease
• It is characterized by an inability to rise from a chair
or get out of bed without help, they may have a
tendency to fall when standing or turning, and they
may freeze or stumble when walking.
• Around-the-clock assistance is required at this stage
to reduce the risk of falling and help the patient with
all daily activities. At stage five, the patient may also
experience hallucinations or delusions.
DIAGNOSIS
• There’s no specific test for diagnosing Parkinson’s.
Diagnosis is made based on health history, a physical and
neurological exam, as well as a review of signs and
symptoms.
• Imaging tests, such as a CAT scan or MRI, may be used to
rule out other conditions. A dopamine transporter
(DAT) scan may also be used. While these tests don’t
confirm Parkinson’s, they can help rule out other
conditions and support the doctor’s diagnosis.
MRI & CT SCAN
A. Normal
B. Stage 1
C. Stage 2
D. Stage 3
E. Stage 4
F. Stage 5
TREATMENT
• Medications can control the symptoms of Parkinson's diseases.
• Following are the drugs used in the treatment:
• Levodopa-Dopamine precursor.
• Carbidopa-Peripheral decarboxylase inhibitor.
• Bromocriptine-Dopaminergic agonist.
• Selegilne
• Amantadine-Dopamine facilitator.
• Biperiden-Anticholinergics.
• Carbidopa +Levodopa (sinmet) is the 1st choice of drug.On
combination with carbidopa many common side effects of
levodopa, such as nausea, vomiting, and irregular heart
rhythms can be prevented.
• Tolcapone and entacapone. When you take levodopa, a
chemical in your body called COMT makes part of the drug
useless. The drugs tolcapone (Tasmar) and entacapone
(Comtan) block COMT, so the brain can use levodopa more
effectively, which eases Parkinson's symptoms.
• Levodopa is said to be "Gold standard treatment".
Mechanism of
Action
PARKINSON’S SURGERY
• Surgical interventions are reserved for people who don’t respond
to medication, therapy, and lifestyle changes.
• Two primary types of surgery are used to treat Parkinson’s:
1. Deep BrainStimulation
2. Pump- Delivered Therapy
• Deep brain stimulation
• During deep brain stimulation (DBS), surgeons implant electrodes in
specific parts of the brain. A generator connected to the electrodes
sends out pulses to help reduce symptoms.
• Pump-delivered therapy
• In January 2015, the U.S. Food and Drug Administration (FDA)
approved a pump-delivered therapy called Duopa.
• The pump delivers a combination of levodopa and carbidopa. In
order to use the pump, your doctor will have to perform a surgical
procedure to place the pump near the small intestine.
DBS
PARKINSON’S PROGNOSIS
• Complications from Parkinson’s can greatly reduce quality of life and
prognosis. For example, individuals with Parkinson’s can experience
dangerous falls, as well as blood clots in the lungs and legs. These
complications can be fatal.
• Proper treatment improves your prognosis, and it increases life
expectancy.
• It may not be possible to slow the progression of Parkinson’s, but you
can work to overcome the obstacles and complications to have a better
quality of life for as long as possible.
PREVENTION AND DIET
• Go Organic (and Local)
• Eat fresh raw vegetables.
• Incorporate Omega-3 Fatty Acids IntoYour Diet.
• Drink green tea.
• Do regular aerobic exercise.
• Intake of sufficient quantity of CoQ10 enzyme can prevent
or slow down the chances of Parkinson's diseases.Avoid
stress.
Reference : Parkinson disease
https://www.healthline.com/health/parkinsons
https://en.m.wikipedia.org/wiki/Parkinson%27s_disease
https://www.parkinson.org/understanding-parkinsons/what-is-parkinsons
Thank you

More Related Content

What's hot

Parkinsonism.ppt
Parkinsonism.pptParkinsonism.ppt
Parkinsonism.pptShama
 
Parkinson disease
Parkinson diseaseParkinson disease
Parkinson disease
Yasser Alzainy
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Diseaseguest27ee33
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
Anindya Banerjee
 
PARKINSON'S DISEASE Presentation by Rajee
PARKINSON'S DISEASE  Presentation by RajeePARKINSON'S DISEASE  Presentation by Rajee
PARKINSON'S DISEASE Presentation by Rajee
Rajee Ravindran
 
Parkinson's Disease by Dr. Aryan
Parkinson's Disease by Dr. AryanParkinson's Disease by Dr. Aryan
Parkinson's Disease by Dr. Aryan
Dr. Aryan (Anish Dhakal)
 
Understanding the Parkinson's disease
Understanding the Parkinson's diseaseUnderstanding the Parkinson's disease
Understanding the Parkinson's disease
Syed Nayyer Alvi
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease
test
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.DDr.Sohel Memon
 
Parkinsonism, Parkinson’s Disease
Parkinsonism, Parkinson’s Disease Parkinsonism, Parkinson’s Disease
Parkinsonism, Parkinson’s Disease
Dr. Siddharth Dutta
 
Parkinson's disease by waheed javed
Parkinson's disease by waheed javedParkinson's disease by waheed javed
Parkinson's disease by waheed javed
Waheed javed, Student at INDUS COLLEGE OF NURSING
 
Parkinson Disease
Parkinson DiseaseParkinson Disease
Parkinson Disease
yuyuricci
 
Parkinson disease
Parkinson disease Parkinson disease
Parkinson disease
Itsayesha
 
Parkinson stand 03.12
Parkinson stand 03.12Parkinson stand 03.12
Parkinson stand 03.12
Mohamed Jammal
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptx
Ameena Kadar
 
parkinsons disease recent updates
parkinsons disease recent updatesparkinsons disease recent updates
parkinsons disease recent updates
NeurologyKota
 
Myoclonus
MyoclonusMyoclonus
Myoclonus
Sachin Adukia
 
Peripheral neuropathy
Peripheral neuropathyPeripheral neuropathy
Peripheral neuropathy
anoop k r
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
mistygirl91
 

What's hot (20)

Parkinsonism.ppt
Parkinsonism.pptParkinsonism.ppt
Parkinsonism.ppt
 
Parkinson disease
Parkinson diseaseParkinson disease
Parkinson disease
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
PARKINSON'S DISEASE Presentation by Rajee
PARKINSON'S DISEASE  Presentation by RajeePARKINSON'S DISEASE  Presentation by Rajee
PARKINSON'S DISEASE Presentation by Rajee
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinson's Disease by Dr. Aryan
Parkinson's Disease by Dr. AryanParkinson's Disease by Dr. Aryan
Parkinson's Disease by Dr. Aryan
 
Understanding the Parkinson's disease
Understanding the Parkinson's diseaseUnderstanding the Parkinson's disease
Understanding the Parkinson's disease
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.D
 
Parkinsonism, Parkinson’s Disease
Parkinsonism, Parkinson’s Disease Parkinsonism, Parkinson’s Disease
Parkinsonism, Parkinson’s Disease
 
Parkinson's disease by waheed javed
Parkinson's disease by waheed javedParkinson's disease by waheed javed
Parkinson's disease by waheed javed
 
Parkinson Disease
Parkinson DiseaseParkinson Disease
Parkinson Disease
 
Parkinson disease
Parkinson disease Parkinson disease
Parkinson disease
 
Parkinson stand 03.12
Parkinson stand 03.12Parkinson stand 03.12
Parkinson stand 03.12
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptx
 
parkinsons disease recent updates
parkinsons disease recent updatesparkinsons disease recent updates
parkinsons disease recent updates
 
Myoclonus
MyoclonusMyoclonus
Myoclonus
 
Peripheral neuropathy
Peripheral neuropathyPeripheral neuropathy
Peripheral neuropathy
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 

Similar to PARKINSON DISEASE

barkinson's disease
barkinson's diseasebarkinson's disease
barkinson's diseaseSadiiq Cabdi
 
Assessment and Management of Parkinson.pptx
Assessment and Management of Parkinson.pptxAssessment and Management of Parkinson.pptx
Assessment and Management of Parkinson.pptx
NimraFaraz
 
PARKINSON’S DISEASE PPT.pptx
PARKINSON’S DISEASE PPT.pptxPARKINSON’S DISEASE PPT.pptx
PARKINSON’S DISEASE PPT.pptx
BharatiyaSiddharth
 
Parkinson's Disease.pptx
Parkinson's Disease.pptxParkinson's Disease.pptx
Parkinson's Disease.pptx
Sudipta Roy
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
Basil Wilson
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
Zehva Khan
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
Mohamed Afzel
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
Jayanth Malakar
 
PD.pptx
PD.pptxPD.pptx
PD.pptx
ParulBawa6
 
PARKINSON.pptx
PARKINSON.pptxPARKINSON.pptx
PARKINSON.pptx
sakshiupadhyay88
 
PARKINSONISM & TYPE 2 DIABETES
PARKINSONISM &  TYPE 2 DIABETES PARKINSONISM &  TYPE 2 DIABETES
PARKINSONISM & TYPE 2 DIABETES
KrishnaDeshpande9
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
Angellavanya1
 
Parkinsonism disorder
Parkinsonism disorderParkinsonism disorder
Parkinsonism disorder
TareqAziz28
 
Parkinson handbook
Parkinson handbookParkinson handbook
Parkinson handbookOpti Mizam
 
Anti parkinsonian drugs
Anti parkinsonian drugsAnti parkinsonian drugs
Anti parkinsonian drugs
Dr. Mohit Kulmi
 
parkinsons disease
parkinsons diseaseparkinsons disease
parkinsons diseasedrnokku
 
Anti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruvaAnti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruva
Mahi Yeruva
 

Similar to PARKINSON DISEASE (20)

barkinson's disease
barkinson's diseasebarkinson's disease
barkinson's disease
 
Parkinson’s Disease
Parkinson’s DiseaseParkinson’s Disease
Parkinson’s Disease
 
parkinsons disease
parkinsons diseaseparkinsons disease
parkinsons disease
 
Assessment and Management of Parkinson.pptx
Assessment and Management of Parkinson.pptxAssessment and Management of Parkinson.pptx
Assessment and Management of Parkinson.pptx
 
PARKINSON’S DISEASE PPT.pptx
PARKINSON’S DISEASE PPT.pptxPARKINSON’S DISEASE PPT.pptx
PARKINSON’S DISEASE PPT.pptx
 
Parkinson's Disease.pptx
Parkinson's Disease.pptxParkinson's Disease.pptx
Parkinson's Disease.pptx
 
Parkinsons paper
Parkinsons paperParkinsons paper
Parkinsons paper
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
 
PD.pptx
PD.pptxPD.pptx
PD.pptx
 
PARKINSON.pptx
PARKINSON.pptxPARKINSON.pptx
PARKINSON.pptx
 
PARKINSONISM & TYPE 2 DIABETES
PARKINSONISM &  TYPE 2 DIABETES PARKINSONISM &  TYPE 2 DIABETES
PARKINSONISM & TYPE 2 DIABETES
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
 
Parkinsonism disorder
Parkinsonism disorderParkinsonism disorder
Parkinsonism disorder
 
Parkinson handbook
Parkinson handbookParkinson handbook
Parkinson handbook
 
Anti parkinsonian drugs
Anti parkinsonian drugsAnti parkinsonian drugs
Anti parkinsonian drugs
 
parkinsons disease
parkinsons diseaseparkinsons disease
parkinsons disease
 
Anti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruvaAnti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruva
 

Recently uploaded

Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 

Recently uploaded (20)

Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 

PARKINSON DISEASE

  • 1. By- Vijaiy. S & Shreedevi. R RVS COLLEGE OF PHARMACY, SULUR, COIMBATORE, TAMILNADU.
  • 2. INTRODUCTION • It is a slowly progressive degenerative disease of nervous system associated with damage to basal ganglia followed by destruction of substantia nigra. • This causes decrease in dopamine level causing parkinsons diseases. • It was discovered by English physician James Parkinson in 1817. • It is also called as Parkinsonism/Paralysis agitans. • It is found to be 14th major cause for death in US.
  • 3.
  • 5. SYMPTOMS • Mild noticeable tremor in one hand. • Bradykinesia • Rigid muscles. • Poverty of movements-Loss of activties including blinking,smiling etc. • Gait • Emotional changes. • Dementia. • And due to stages
  • 6. CAUSES • Encephalitis • Cerebral arteriosclerosis • Drugs - Prolonged use of Antihpertensive drugs (Eg:Reserpine) • Low levels of dopamine and norepinephrine, a substance that regulates dopamine, have been linked with Parkinson’s.
  • 7. • Research has identified groups of people who are more likely to develop the condition. These include: • Sex: Men are one and a half times more likely to get Parkinson’s than women. • Race: Whites are more likely to get Parkinson’s than African Americans or Asians. • Age: Parkinson’s usually appears between the ages of 50 and 60. It only occurs before the age of 40 in 5-10 percent of cases. • Family history: People who have close family members with Parkinson’s disease are more likely to develop Parkinson’s disease, too. • Toxins: Exposure to certain toxins may increase the risk of Parkinson’s disease. • Head injury: People who experience head injuries may be more likely to develop Parkinson’s disease.
  • 9. Stage one of Parkinson’s disease • The symptoms of PD are mild and only seen on one side of the body (unilateral involvement), and there is usually minimal or no functional impairment • Symptoms at stage one may include tremor, such as intermittent tremor of one hand, rigidity, or one hand or leg may feel more clumsy than another, or one side of the face may be affected, impacting the expression. • This stage is very difficult to diagnose and a physician may wait to see if the symptoms get worse over time before making a formal diagnosis
  • 10. Stage two of Parkinson’s disease • It is characterized by symptoms on both sides of the body (bilateral involvement) or at the midline without impairment to balance. • Stage two may develop months or years after stage one. Symptoms of PD in stage two may include the loss of facial expression on both sides of the face, decreased blinking, speech abnormalities, soft voice, monotone voice, fading volume after starting to speak loudly, slurring speech, stiffness or rigidity of the muscles in the trunk that may result in neck or back pain, stooped posture, stooped posture, and general slowness in all activities of daily living. • Diagnosis may be easy at this stage if the patient has a tremor.
  • 11. Stage three of Parkinson’s disease • It is considered mid-stage and is characterized by loss of balance and slowness of movement. • Balance is compromised by the inability to make the rapid, automatic and involuntary adjustments necessary to prevent falling, and falls are common at this stage. • All other symptoms of PD are also present at this stage, and generally diagnosis is not in doubt at stage three. • Often a physician will diagnose impairments in reflexes at this stage by standing behind the patient and gently pulling the shoulders to determine if the patient has trouble maintaining balance and falls backward (the physician of course will not let the patient fall).
  • 12. Stage four of Parkinson’s disease • Patients with stage four PD may be able to walk and stand unassisted, but they are noticeably incapacitated. Many use a walker to help them. • At this stage, the patient is unable to live an independent life and needs assistance with some activities of daily living. The necessity for help with daily living defines this stage. If the patient is still able to live alone, it is still defined as stage three.
  • 13. Stage five of Parkinson’s disease • It is characterized by an inability to rise from a chair or get out of bed without help, they may have a tendency to fall when standing or turning, and they may freeze or stumble when walking. • Around-the-clock assistance is required at this stage to reduce the risk of falling and help the patient with all daily activities. At stage five, the patient may also experience hallucinations or delusions.
  • 14. DIAGNOSIS • There’s no specific test for diagnosing Parkinson’s. Diagnosis is made based on health history, a physical and neurological exam, as well as a review of signs and symptoms. • Imaging tests, such as a CAT scan or MRI, may be used to rule out other conditions. A dopamine transporter (DAT) scan may also be used. While these tests don’t confirm Parkinson’s, they can help rule out other conditions and support the doctor’s diagnosis.
  • 15. MRI & CT SCAN A. Normal B. Stage 1 C. Stage 2 D. Stage 3 E. Stage 4 F. Stage 5
  • 16.
  • 17.
  • 18. TREATMENT • Medications can control the symptoms of Parkinson's diseases. • Following are the drugs used in the treatment: • Levodopa-Dopamine precursor. • Carbidopa-Peripheral decarboxylase inhibitor. • Bromocriptine-Dopaminergic agonist. • Selegilne • Amantadine-Dopamine facilitator. • Biperiden-Anticholinergics.
  • 19. • Carbidopa +Levodopa (sinmet) is the 1st choice of drug.On combination with carbidopa many common side effects of levodopa, such as nausea, vomiting, and irregular heart rhythms can be prevented. • Tolcapone and entacapone. When you take levodopa, a chemical in your body called COMT makes part of the drug useless. The drugs tolcapone (Tasmar) and entacapone (Comtan) block COMT, so the brain can use levodopa more effectively, which eases Parkinson's symptoms. • Levodopa is said to be "Gold standard treatment".
  • 21. PARKINSON’S SURGERY • Surgical interventions are reserved for people who don’t respond to medication, therapy, and lifestyle changes. • Two primary types of surgery are used to treat Parkinson’s: 1. Deep BrainStimulation 2. Pump- Delivered Therapy • Deep brain stimulation • During deep brain stimulation (DBS), surgeons implant electrodes in specific parts of the brain. A generator connected to the electrodes sends out pulses to help reduce symptoms.
  • 22. • Pump-delivered therapy • In January 2015, the U.S. Food and Drug Administration (FDA) approved a pump-delivered therapy called Duopa. • The pump delivers a combination of levodopa and carbidopa. In order to use the pump, your doctor will have to perform a surgical procedure to place the pump near the small intestine.
  • 23. DBS
  • 24. PARKINSON’S PROGNOSIS • Complications from Parkinson’s can greatly reduce quality of life and prognosis. For example, individuals with Parkinson’s can experience dangerous falls, as well as blood clots in the lungs and legs. These complications can be fatal. • Proper treatment improves your prognosis, and it increases life expectancy. • It may not be possible to slow the progression of Parkinson’s, but you can work to overcome the obstacles and complications to have a better quality of life for as long as possible.
  • 25.
  • 26. PREVENTION AND DIET • Go Organic (and Local) • Eat fresh raw vegetables. • Incorporate Omega-3 Fatty Acids IntoYour Diet. • Drink green tea. • Do regular aerobic exercise. • Intake of sufficient quantity of CoQ10 enzyme can prevent or slow down the chances of Parkinson's diseases.Avoid stress.
  • 27. Reference : Parkinson disease https://www.healthline.com/health/parkinsons https://en.m.wikipedia.org/wiki/Parkinson%27s_disease https://www.parkinson.org/understanding-parkinsons/what-is-parkinsons